Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul 18;34(8):547-555.
doi: 10.1136/bmjqs-2025-018558.

Time to de-implementation of low-value cancer screening practices: a narrative review

Affiliations
Review

Time to de-implementation of low-value cancer screening practices: a narrative review

Jennifer H LeLaurin et al. BMJ Qual Saf. .

Abstract

The continued use of low-value cancer screening practices not only represents healthcare waste but also a potential cascade of invasive diagnostic procedures and patient anxiety and distress. While prior research has shown it takes an average of 15 years to implement evidence-based practices in cancer control, little is known about how long it takes to de-implement low-value cancer screening practices. We reviewed evidence on six United States Preventive Services Task Force 'Grade D' cancer screening practices: (1) cervical cancer screening in women<21 years and >65 years, (2) prostate cancer screening in men≥70 years and (3) ovarian, (4) thyroid, (5) testicular and (6) pancreatic cancer screening in asymptomatic adults. We measured the time from a landmark publication supporting the guideline publication and subsequent de-implementation, defined as a 50% reduction in the use of the practice in routine care. The pace of de-implementation was assessed using nationally representative surveillance systems and peer-reviewed literature from the USA. We found the time to de-implementation of cervical cancer screening was 4 years for women<21 and 16 years for women>65. Prostate screening in men ≥70 has not reached a 50% reduction in use since the 2012 guideline release. We did not identify sufficient evidence to measure the time to de-implementation for ovarian, thyroid, testicular and pancreatic cancer screening in asymptomatic adults. Surveillance of low-value cancer screening is sparse, posing a clear barrier to tracking the de-implementation of these screening practices. Improving the systematic measurement of low-value cancer control practices is imperative for assessing the impact of de-implementation on patient outcomes, healthcare delivery and healthcare costs.

Keywords: Implementation science; Quality measurement; Standards of care.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1. Time to de-implementation of selected USPSTF Grade D cancer screening practices. USPSTF, United States Preventive Services Task Force.

Similar articles

References

    1. Alishahi Tabriz A, Turner K, Clary A, et al. De-implementing low-value care in cancer care delivery: a systematic review. Implement Sci. 2022;17:24. doi: 10.1186/s13012-022-01197-5. - DOI - PMC - PubMed
    1. Elshaug AG, Rosenthal MB, Lavis JN, et al. Levers for addressing medical underuse and overuse: achieving high-value health care. The Lancet. 2017;390:191–202. doi: 10.1016/S0140-6736(16)32586-7. - DOI - PubMed
    1. Shrank WH, Rogstad TL, Parekh N. Waste in the US Health Care System: Estimated Costs and Potential for Savings. JAMA. 2019;322:1501–9. doi: 10.1001/jama.2019.13978. - DOI - PubMed
    1. Baxi SS, Kale M, Keyhani S, et al. Overuse of Health Care Services in the Management of Cancer: A Systematic Review. Med Care. 2017;55:723–33. doi: 10.1097/MLR.0000000000000734. - DOI - PMC - PubMed
    1. Rocque GB, Williams CP, Jackson BE, et al. Choosing Wisely: Opportunities for Improving Value in Cancer Care Delivery? J Oncol Pract. 2017;13:e11–21. doi: 10.1200/JOP.2016.015396. - DOI - PMC - PubMed

LinkOut - more resources